| Feb 17, 2026 |
Feb 18, 2026 |
Williams Lewis T
|
Director |
Sell |
17.5
|
-18,000
|
-69.70%
|
✗
|
$1.5M |
| Feb 6, 2026 |
Feb 6, 2026 |
Waddill William D.
|
Director |
Sell |
17.5
|
-20,000
|
-71.88%
|
✗
|
$1.7M |
| Jan 23, 2026 |
Jan 27, 2026 |
PATEL DINESH V PH D
|
CEO |
Sell |
17.5
|
-54,273
|
-1.85%
|
✗
|
$4.1M |
| Jan 27, 2026 |
Jan 27, 2026 |
Ali Asif
|
CFO |
Sell |
17.5
|
-46,203
|
-43.37%
|
✗
|
$3.8M |
| Jan 23, 2026 |
Jan 27, 2026 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
17.5
|
-23,151
|
-8.40%
|
✗
|
$1.9M |
| Jan 20, 2026 |
Jan 21, 2026 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
40.0
|
-9,514
|
-8.91%
|
✗
|
$784.7K |
| Jan 20, 2026 |
Jan 21, 2026 |
PATEL DINESH V PH D
|
CEO |
Sell |
37.5
|
-34,438
|
-5.60%
|
✗
|
$2.8M |
| Jan 20, 2026 |
Jan 21, 2026 |
Ali Asif
|
CFO |
Sell |
40.0
|
-8,588
|
-9.91%
|
✗
|
$708.3K |
| Jan 9, 2026 |
Jan 13, 2026 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
SELICK HAROLD E
|
Director |
Neutral |
85.0
|
+2,695
|
6.15%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Waddill William D.
|
Director |
Neutral |
90.0
|
+2,695
|
52.53%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Giraudo Bryan
|
Director |
Neutral |
90.0
|
+2,695
|
11.65%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Williams Lewis T
|
Director |
Neutral |
90.0
|
+2,695
|
52.53%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
O'Dowd Sarah A
|
Director |
Neutral |
90.0
|
+2,695
|
52.53%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
PATEL DINESH V PH D
|
CEO |
Neutral |
90.0
|
+95,400
|
18.36%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Ali Asif
|
CFO |
Neutral |
90.0
|
+25,600
|
41.92%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Neutral |
90.0
|
+25,600
|
31.53%
|
✗
|
- |
| Nov 21, 2025 |
Nov 24, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-440
|
-0.08%
|
✗
|
- |
| Nov 17, 2025 |
Nov 19, 2025 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
42.5
|
-2,712
|
-3.23%
|
✗
|
$229.9K |
| Oct 10, 2025 |
Oct 14, 2025 |
Waddill William D.
|
Director |
Sell |
7.5
|
-12,000
|
-70.05%
|
✓
|
$979.5K |
| Sep 22, 2025 |
Sep 24, 2025 |
Waddill William D.
|
Director |
Sell |
7.5
|
-4,000
|
-43.81%
|
✓
|
$257K |
| Sep 16, 2025 |
Sep 18, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-620
|
-0.12%
|
✗
|
- |
| Aug 27, 2025 |
Aug 29, 2025 |
Waddill William D.
|
Director |
Sell |
10.0
|
-4,000
|
-30.46%
|
✓
|
$237K |
| Jul 25, 2025 |
Jul 28, 2025 |
PATEL DINESH V PH D
|
CEO |
Sell |
20.0
|
-10,415
|
-1.96%
|
✗
|
$570.5K |
| Jul 21, 2025 |
Jul 23, 2025 |
PATEL DINESH V PH D
|
CEO |
Sell |
37.5
|
-27,444
|
-4.91%
|
✗
|
$2.9M |
| Jul 16, 2025 |
Jul 18, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
37.5
|
-5,000
|
-0.89%
|
✗
|
- |
| Jun 13, 2025 |
Jun 17, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
45.0
|
-1,355
|
-0.24%
|
✗
|
- |
| Jun 9, 2025 |
Jun 11, 2025 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
17.5
|
-20,000
|
-10.65%
|
✗
|
$1.1M |
| Apr 28, 2025 |
Apr 30, 2025 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 22, 2025 |
Apr 23, 2025 |
Ali Asif
|
CFO |
Sell |
42.5
|
-1,756
|
-2.80%
|
✗
|
$80.8K |
| Mar 17, 2025 |
Mar 19, 2025 |
Waddill William D.
|
Director |
Sell |
15.0
|
-4,000
|
-23.35%
|
✓
|
$217K |
| Mar 13, 2025 |
Mar 14, 2025 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
17.5
|
-30,514
|
-26.67%
|
✗
|
$1.7M |
| Mar 12, 2025 |
Mar 14, 2025 |
Ali Asif
|
CFO |
Sell |
17.5
|
-24,903
|
-28.39%
|
✗
|
$1.5M |
| Mar 5, 2025 |
Mar 5, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 19, 2025 |
Feb 20, 2025 |
PATEL DINESH V PH D
|
CEO |
Sell |
45.0
|
-5,359
|
-0.98%
|
✗
|
$204.6K |
| Jan 16, 2025 |
Jan 17, 2025 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Neutral |
47.5
|
-3,640
|
-4.16%
|
✗
|
- |
| Jan 15, 2025 |
Jan 17, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
47.5
|
-12,636
|
-2.26%
|
✗
|
- |
| Jan 16, 2025 |
Jan 17, 2025 |
Ali Asif
|
CFO |
Neutral |
47.5
|
-3,918
|
-5.87%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Waddill William D.
|
Director |
Neutral |
90.0
|
+5,130
|
42.75%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
O'Dowd Sarah A
|
Director |
Neutral |
90.0
|
+5,130
|
100.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Williams Lewis T
|
Director |
Neutral |
90.0
|
+5,130
|
100.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
SELICK HAROLD E
|
Director |
Neutral |
90.0
|
+5,130
|
18.32%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
PATEL DINESH V PH D
|
CEO |
Neutral |
90.0
|
+149,800
|
36.67%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Giraudo Bryan
|
Director |
Neutral |
90.0
|
+5,130
|
28.50%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Neutral |
90.0
|
+41,088
|
88.47%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Ali Asif
|
CFO |
Neutral |
90.0
|
+31,779
|
90.90%
|
✗
|
- |
| Nov 26, 2024 |
Nov 27, 2024 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
17.5
|
-31,529
|
-18.45%
|
✗
|
$1.4M |
| Nov 25, 2024 |
Nov 27, 2024 |
Gupta Suneel
|
Chief Development Officer |
Sell |
16.3
|
-122,628
|
-18.99%
|
✗
|
$5.6M |
| Nov 25, 2024 |
Nov 27, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
17.5
|
-107,000
|
-7.76%
|
✗
|
$4.7M |
| Nov 19, 2024 |
Nov 21, 2024 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-1,000
|
-0.19%
|
✗
|
- |
| Nov 15, 2024 |
Nov 19, 2024 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
42.5
|
-1,906
|
-3.94%
|
✗
|
$78.1K |
| Sep 11, 2024 |
Sep 13, 2024 |
Ali Asif
|
CFO |
Sell |
20.0
|
-14,203
|
-16.88%
|
✗
|
$631.9K |
| Sep 10, 2024 |
Sep 12, 2024 |
Waddill William D.
|
Director |
Sell |
7.5
|
-8,000
|
-40.00%
|
✓
|
$360K |
| Jul 24, 2024 |
Jul 26, 2024 |
Waddill William D.
|
Director |
Sell |
7.5
|
-8,000
|
-40.00%
|
✓
|
$320K |
| Jun 13, 2024 |
Jun 17, 2024 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-1,000
|
-0.19%
|
✗
|
- |
| Jun 7, 2024 |
Jun 11, 2024 |
Waddill William D.
|
Director |
Sell |
7.5
|
-8,000
|
-40.00%
|
✓
|
$280K |
| Jun 7, 2024 |
Jun 11, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
27.5
|
-35,000
|
-6.36%
|
✓
|
$1.2M |
| Apr 18, 2024 |
Apr 19, 2024 |
Ali Asif
|
CFO |
Sell |
46.3
|
-1,234
|
-3.21%
|
✗
|
$31K |
| Apr 1, 2024 |
Apr 2, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
35.0
|
-25,000
|
-4.35%
|
✓
|
$707.8K |
| Mar 7, 2024 |
Mar 11, 2024 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 1, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
35.0
|
-30,000
|
-4.96%
|
✓
|
$948.6K |
| Mar 1, 2024 |
Mar 1, 2024 |
Waddill William D.
|
Director |
Sell |
7.5
|
-12,975
|
-51.95%
|
✓
|
$406.6K |
| Feb 29, 2024 |
Mar 1, 2024 |
Ali Asif
|
CFO |
Sell |
20.0
|
-24,187
|
-12.96%
|
✗
|
$764.4K |
| Feb 26, 2024 |
Feb 28, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
40.0
|
-10,915
|
-1.77%
|
✗
|
$322.3K |
| Feb 26, 2024 |
Feb 28, 2024 |
Gupta Suneel
|
Chief Development Officer |
Sell |
42.5
|
-4,282
|
-2.28%
|
✗
|
$126.4K |
| Feb 15, 2024 |
Feb 20, 2024 |
PATEL DINESH V PH D
|
CEO |
Sell |
45.0
|
-3,717
|
-0.60%
|
✗
|
$104.9K |
| Jan 16, 2024 |
Jan 18, 2024 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
48.8
|
-427
|
-0.88%
|
✗
|
$10.5K |
| Jan 16, 2024 |
Jan 18, 2024 |
Ali Asif
|
CFO |
Sell |
46.3
|
-1,452
|
-2.79%
|
✗
|
$35.8K |
| Jan 9, 2024 |
Jan 11, 2024 |
Gupta Suneel
|
Chief Development Officer |
Sell |
41.3
|
-5,000
|
-2.60%
|
✓
|
$125K |
| Jan 2, 2024 |
Jan 4, 2024 |
Waddill William D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
O'Dowd Sarah A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
Gupta Suneel
|
Chief Development Officer |
Neutral |
90.0
|
+19,250
|
11.44%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
Williams Lewis T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
PATEL DINESH V PH D
|
CEO |
Neutral |
90.0
|
+84,875
|
15.88%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
Giraudo Bryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 15, 2023 |
Jan 4, 2024 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Sell |
91.3
|
+24,402
|
100.11%
|
✗
|
$30K |
| Jan 2, 2024 |
Jan 4, 2024 |
Ali Asif
|
CFO |
Neutral |
90.0
|
+21,000
|
67.66%
|
✗
|
- |
| Dec 13, 2023 |
Dec 15, 2023 |
PATEL DINESH V PH D
|
CEO |
Sell |
20.0
|
-75,000
|
-12.31%
|
✓
|
$1.5M |
| Oct 26, 2023 |
Oct 30, 2023 |
Swisher Daniel N JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 30, 2023 |
Swisher Daniel N JR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 19, 2023 |
Oct 23, 2023 |
Gupta Suneel
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 18, 2023 |
Oct 19, 2023 |
PATEL DINESH V PH D
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 31, 2023 |
Jun 2, 2023 |
Gupta Suneel
|
Chief Development Officer |
Sell |
90.0
|
+7,850
|
5.60%
|
✗
|
$108.2K |
| Feb 22, 2023 |
Jun 2, 2023 |
PATEL DINESH V PH D
|
CEO |
Sell |
67.5
|
+7,835
|
0.44%
|
✗
|
$317.1K |
| May 31, 2023 |
Jun 2, 2023 |
Ali Asif
|
CFO |
Sell |
95.0
|
+7,850
|
33.86%
|
✗
|
$108.2K |
| Apr 18, 2023 |
Apr 19, 2023 |
Ali Asif
|
CFO |
Sell |
46.3
|
-1,189
|
-4.88%
|
✗
|
$27.6K |
| Apr 10, 2023 |
Apr 11, 2023 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Giraudo Bryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Williams Lewis T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Waddill William D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Noonberg Sarah B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
O'Dowd Sarah A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
SELICK HAROLD E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Gupta Suneel
|
Chief Development Officer |
Neutral |
90.0
|
+20,625
|
17.54%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
Ali Asif
|
CFO |
Neutral |
90.0
|
+10,625
|
77.27%
|
✗
|
- |
| Jan 16, 2023 |
Jan 18, 2023 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Neutral |
90.0
|
+3,125
|
14.71%
|
✗
|
- |
| May 4, 2022 |
Jan 18, 2023 |
PATEL DINESH V PH D
|
CEO |
Neutral |
37.5
|
-6,116
|
-0.52%
|
✗
|
- |
| Nov 16, 2022 |
Nov 17, 2022 |
Liu David Y
|
Chief R&D Strategy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 15, 2022 |
Nov 17, 2022 |
MOLINA ARTURO MD
|
Chief Medical Officer |
Neutral |
90.0
|
+21,250
|
100.00%
|
✗
|
- |